Gordon Waldron
Vorsitzender bei Antabio SAS
Profil
Gordon Waldron is currently the Chairman at Antabio SAS.
He previously worked as the Finance Director at Texas Instruments Incorporated, Director at Neorphys SAS, Controller at Spie Batignolles SAS, Chief Financial Officer at Synt:em SA, and Chief Financial Officer at Novexel SA. From 2010 to 2015, he served as the CFO, Executive VP & Head-Investor Relations at SuperSonic Imagine SA. Mr. Waldron obtained his undergraduate degree from Duke University in 1988.
Aktive Positionen von Gordon Waldron
Unternehmen | Position | Beginn |
---|---|---|
Antabio SAS
Antabio SAS Pharmaceuticals: MajorHealth Technology Antabio SAS operates as a biopharmaceutical company which develops drugs for the treatment and prevention of antibiotic-resistant bacterial infections. The firm focuses bacterial disease research, drug design, antibiotic combination testing, and in vitro technology development operations. The company was founded by Marc Lemonnier and Aymeric Dugray on October 15, 2009 and is headquartered in Labege, France. | Vorsitzender | - |
Ehemalige bekannte Positionen von Gordon Waldron
Unternehmen | Position | Ende |
---|---|---|
SUPERSONIC IMAGINE | Finanzdirektor/CFO | 15.04.2015 |
Neorphys SAS
Neorphys SAS Pharmaceuticals: MajorHealth Technology Founded in September 2005 by Dr Roger LAHANA, CEO, and Karine LARBOURET, Director of Operations, Neorphys is a company which discovers and develops novel, proprietary analgesic drug candidates with low side effects, especially with regard to gastro-intestinal transit. This is why the most advanced drug candidate is developed for visceral pain management. Beside the co-founders, Neorphys scientists, all PhD's or equivalent, share a strong expertise in opioids and acute pain as well as in behavioral pharmacology. They have a proven track record of success in using discovery techniques such as medicinal chemistry, cell biology, toxicology and relevant animal assays. | Direktor/Vorstandsmitglied | 11.03.2014 |
Spie Batignolles SAS
Spie Batignolles SAS Engineering & ConstructionIndustrial Services Spie Batignolles SA provides construction services. It specializes in engineering, civil works, sanitation, maintenance, and remodeling solutions for commercial buildings and industrial projects. The company was founded in 1968 and is headquartered in Neuilly-sur-Seine, France. | Comptroller/Controller/Auditor | - |
TEXAS INSTRUMENTS INCORPORATED | Finanzdirektor/CFO | - |
Novexel SA
Novexel SA Pharmaceuticals: MajorHealth Technology Novexel SA researches and develops anti-infective drugs for the treatment of bacterial and fungal infections. The firm focuses on discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance. The company was founded in December 2004 and is headquartered in Romainville, France. | Finanzdirektor/CFO | - |
Ausbildung von Gordon Waldron
Duke University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
TEXAS INSTRUMENTS INCORPORATED | Electronic Technology |
Private Unternehmen | 6 |
---|---|
Synt:em SA
Synt:em SA Pharmaceuticals: MajorHealth Technology Synt:em SA researches and manufactures drugs for the treatment of pain and cancer. The company specializes in the discovery and development of Central Nervous System (CNS) medicines and novel therapeutics for the treatment diseases. It was founded in 1995 by Michel Kaczorek and Caroline Roussel and is headquartered in Nîmes, France. | Health Technology |
Novexel SA
Novexel SA Pharmaceuticals: MajorHealth Technology Novexel SA researches and develops anti-infective drugs for the treatment of bacterial and fungal infections. The firm focuses on discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance. The company was founded in December 2004 and is headquartered in Romainville, France. | Health Technology |
Neorphys SAS
Neorphys SAS Pharmaceuticals: MajorHealth Technology Founded in September 2005 by Dr Roger LAHANA, CEO, and Karine LARBOURET, Director of Operations, Neorphys is a company which discovers and develops novel, proprietary analgesic drug candidates with low side effects, especially with regard to gastro-intestinal transit. This is why the most advanced drug candidate is developed for visceral pain management. Beside the co-founders, Neorphys scientists, all PhD's or equivalent, share a strong expertise in opioids and acute pain as well as in behavioral pharmacology. They have a proven track record of success in using discovery techniques such as medicinal chemistry, cell biology, toxicology and relevant animal assays. | Health Technology |
SuperSonic Imagine SA
SuperSonic Imagine SA Medical SpecialtiesHealth Technology SuperSonic Imagine SA specializes in ultrasound medical imaging. The company designs, develops and markets a new generation ultrasound system, Aixplorer with an UltraFastTM platform that can acquire images faster than conventional ultrasound systems. Its products are used for general imaging, vascular, hepatology, gastroenterology, and research procedures. It operates under the Aixplorer trademark. SuperSonic Imagine was founded by Jacques Souquet, Armen Sarvazyan, Claude Cohen-Bacrie, Damien Dolimier, Georges Charpak, Jérémy Bercoff, Mickaël Tanter, Mathias Fink and Marianne Leven on March 10, 2005 and is headquartered in Aix-en-Provence, France. | Health Technology |
Spie Batignolles SAS
Spie Batignolles SAS Engineering & ConstructionIndustrial Services Spie Batignolles SA provides construction services. It specializes in engineering, civil works, sanitation, maintenance, and remodeling solutions for commercial buildings and industrial projects. The company was founded in 1968 and is headquartered in Neuilly-sur-Seine, France. | Industrial Services |
Antabio SAS
Antabio SAS Pharmaceuticals: MajorHealth Technology Antabio SAS operates as a biopharmaceutical company which develops drugs for the treatment and prevention of antibiotic-resistant bacterial infections. The firm focuses bacterial disease research, drug design, antibiotic combination testing, and in vitro technology development operations. The company was founded by Marc Lemonnier and Aymeric Dugray on October 15, 2009 and is headquartered in Labege, France. | Health Technology |